CN113440418A - Dental polymerizable composition - Google Patents

Dental polymerizable composition Download PDF

Info

Publication number
CN113440418A
CN113440418A CN202110295880.XA CN202110295880A CN113440418A CN 113440418 A CN113440418 A CN 113440418A CN 202110295880 A CN202110295880 A CN 202110295880A CN 113440418 A CN113440418 A CN 113440418A
Authority
CN
China
Prior art keywords
meth
acrylate
polymerizable composition
dental
mass
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN202110295880.XA
Other languages
Chinese (zh)
Other versions
CN113440418B (en
Inventor
村上翔悟
柿沼祐亮
佐藤庆太
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GC Corp
Original Assignee
GC Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by GC Corp filed Critical GC Corp
Publication of CN113440418A publication Critical patent/CN113440418A/en
Application granted granted Critical
Publication of CN113440418B publication Critical patent/CN113440418B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K6/00Preparations for dentistry
    • A61K6/80Preparations for artificial teeth, for filling teeth or for capping teeth
    • A61K6/884Preparations for artificial teeth, for filling teeth or for capping teeth comprising natural or synthetic resins
    • A61K6/887Compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds
    • A61K6/889Polycarboxylate cements; Glass ionomer cements
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K6/00Preparations for dentistry
    • A61K6/80Preparations for artificial teeth, for filling teeth or for capping teeth
    • A61K6/884Preparations for artificial teeth, for filling teeth or for capping teeth comprising natural or synthetic resins
    • A61K6/887Compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K6/00Preparations for dentistry
    • A61K6/60Preparations for dentistry comprising organic or organo-metallic additives
    • A61K6/61Cationic, anionic or redox initiators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K6/00Preparations for dentistry
    • A61K6/30Compositions for temporarily or permanently fixing teeth or palates, e.g. primers for dental adhesives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K6/00Preparations for dentistry
    • A61K6/60Preparations for dentistry comprising organic or organo-metallic additives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K6/00Preparations for dentistry
    • A61K6/60Preparations for dentistry comprising organic or organo-metallic additives
    • A61K6/62Photochemical radical initiators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K6/00Preparations for dentistry
    • A61K6/70Preparations for dentistry comprising inorganic additives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K6/00Preparations for dentistry
    • A61K6/70Preparations for dentistry comprising inorganic additives
    • A61K6/71Fillers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K6/00Preparations for dentistry
    • A61K6/80Preparations for artificial teeth, for filling teeth or for capping teeth
    • A61K6/831Preparations for artificial teeth, for filling teeth or for capping teeth comprising non-metallic elements or compounds thereof, e.g. carbon

Landscapes

  • Health & Medical Sciences (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Plastic & Reconstructive Surgery (AREA)
  • Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Biophysics (AREA)
  • Dental Preparations (AREA)

Abstract

The invention provides a dental polymerizable composition having excellent storage stability. The dental polymerizable composition includes a first material containing a (meth) acrylate, a 5-valent vanadium compound, and a thiourea derivative, and a second material containing a (meth) acrylate and an organic peroxide.

Description

Dental polymerizable composition
Technical Field
The present disclosure relates to a dental polymerizable composition.
Background
As a polymerizable composition that can be used even under wet conditions such as in the oral cavity in dental treatment, for example, a polymerizable composition including a first material containing a (meth) acrylate, a thiourea derivative and a vanadium compound and a second material containing a (meth) acrylate and an organic peroxide (organic peroxide) has been proposed (for example, see patent document 1).
Documents of the prior art
Patent document
Patent document 1: japanese laid-open patent publication No. 2012-51856
Disclosure of Invention
However, the hardenability of the polymerizable composition after long-term storage, that is, the storage stability (storage stability) of the polymerizable composition, is desired to be improved.
An object of one aspect of the present disclosure is to provide a polymerizable composition for dental use which is excellent in storage stability.
In one aspect of the present disclosure, a polymerizable dental composition includes a first material including a (meth) acrylate, a 5-valent vanadium compound, and a thiourea derivative, and a second material including a (meth) acrylate and an organic peroxide.
According to one aspect of the present disclosure, a dental polymerizable composition having excellent storage stability can be provided.
Detailed Description
Hereinafter, a mode for carrying out the present disclosure will be described.
< polymerizable composition for dental use >
The dental polymerizable composition of the present embodiment is a 2-dose dental polymerizable composition including a first component containing a (meth) acrylate, a 5-valent vanadium compound, and a thiourea derivative, and a second component containing a (meth) acrylate and an organic peroxide.
The first material and the second material may be in the form of a paste, for example.
The mass ratio of the first component to the second component of the dental polymerizable composition of the present embodiment is usually 10:1 to 1: 10.
The dental polymerizable composition of the present embodiment generally uses a first material and a second material in a mixed manner.
The dental polymerizable composition of the present embodiment is suitably used for dental cements, perceptual hypersensitivity inhibitors (sensifiers for hypersensitivities), dental sealants (dental sealants), and the like.
Hereinafter, components constituting the dental polymerizable composition of the present embodiment will be described.
[ meth (acrylic acid ester ]
In the context of the present description and claims, (meth) acrylate refers to compounds (e.g., monomers, oligomers, prepolymers) that include 1 or more methacryloxy groups and/or acryloxy groups (hereinafter referred to as (meth) acryloxy groups).
The (meth) acrylate may have an acid group or may have no acid group, and the (meth) acrylate included in the first material is preferably an acid group-free (meth) acrylate. This can improve the storage stability of the dental polymerizable composition of the present embodiment.
(meth) acrylate having no acid group)
The (meth) acrylate having no acid group preferably has 2 or more (meth) acryloyloxy groups.
Examples of the (meth) acrylate having no acid group include methyl (meth) acrylate, isopropyl (isopropyl) acrylate, n-butyl (meth) acrylate, isobutyl (meth) acrylate, hydroxypropyl (hydroxypropyl) acrylate, tetrahydrofurfuryl (meth) acrylate, 2-hydroxyethyl (meth) acrylate, 2-hydroxypropyl (2-hydroxypropyl) acrylate, and 2-hydroxypropyl (meth) acrylate, 2-methoxyethyl (meth) acrylate (2-methoxyethyl (meth) acrylate), 2-ethoxyethyl (meth) acrylate (2-ethoxyethyl) acrylate, (2-methylhexyl (meth) acrylate), 2-methylhexyl (meth) acrylate), 2-ethylhexyl (meth) acrylate (2-ethylhexyl (meth) acrylate), benzyl (meth) acrylate), 2-hydroxy-1,3-di (meth) acryloxypropane (2-hydroxy-1, 3-di) acrylate, ethylene glycol di (meth) acrylate, diethylene glycol di (meth) acrylate (diethylene glycol di (meth) acrylate), triethylene glycol di (meth) acrylate (butylene glycol di (meth) acrylate), and butylene glycol di (meth) acrylate, Neopentyl glycol di (meth) acrylate, 1,3-butanediol di (meth) acrylate, 1,4-butanediol di (meth) acrylate, 1,6-hexanediol di (meth) acrylate, trimethylolpropane tri (meth) acrylate, trimethylolethane tri (meth) acrylate, pentaerythritol methane tri (meth) acrylate, pentaerythritol tetra (meth) acrylate, 1,3-butanediol di (meth) acrylate, 1,4-butanediol di (meth) acrylate, 1,6-hexanediol di (meth) acrylate, and pentaerythritol tri (meth) acrylate, Bisphenol A diglycidyl (meth) acrylate (bisphenol-A diglycidyl (meth) acrylate), bis-2- (meth) acryloyloxyethyl-2,2,4-trimethylhexamethylene dicarbonate (di-2- (meth) acryloyloxyethyl-2,2,4-trimethylhexamethylene dicarbamate), 1,3,5-tris [1,3-bis { (meth) acryloyloxy } -2-propoxycarbonylaminohexane ] -1,3,5- (1H,3H,5H) triazine-2,4,6-trione (1,3,5-tris [1,3-bis { (meth) acryloxy } -2-propoxycarbonylaminohexane ] -1,3,5- (1H,3H,5H) triazine-2,4,6-trione), 2- (4-methacryloxy) hydroxyphenyl) phenyl Propane (2,2-bis [4- (3- (meth) acryloxy-2-hydroxyproyl) phenyl ] propane), N '- (2,2,4-trimethylhexamethylene) bis [2- (aminocarboxy) propane-1,3-diol ] tetramethylacrylate (N, N' - (2,2,4-trimethylhexamethylene) bis [2- (aminocarboxy) propane-1,3-diol ] tetramethylacrylate), and the like, and two or more kinds may be used in combination. Among these, 2-hydroxy-1,3-di (meth) acryloyloxypropane, di-2- (meth) acryloyloxyethyl-2,2,4-trimethylhexamethylene dicarbonate, ethylene glycol di (meth) acrylate, neopentyl glycol di (meth) acrylate, triethylene glycol di (meth) acrylate are preferably used from the viewpoint of the mechanical strength of a cured product of the dental polymerizable composition of the present embodiment.
The content of the acid group-free (meth) acrylate in the polymerizable composition for dental use of the present embodiment is preferably 10 to 95% by mass, and more preferably 15 to 80% by mass. When the content of the acid group-free (meth) acrylate in the polymerizable composition for dental use of the present embodiment is 10 mass% or more and 95 mass% or less, the workability of the polymerizable composition for dental use of the present embodiment can be improved.
(meth) acrylate having acid group)
Examples of the (meth) acrylate having an acid group include (meth) acrylates having a phosphate group, (meth) acrylates having a pyrophosphate group, (meth) acrylates having a thiophosphate group, (meth) acrylates having a carboxyl group, (meth) acrylates having a sulfonic acid group, and (meth) acrylates having a phosphonic acid group, and two or more kinds of these (meth) acrylates may be used in combination. Among these, from the viewpoint of solubility of a tooth surface staining layer (smear layer) and decalcification (decalcification) property of the dental polymerizable composition of the present embodiment, it is preferable to use a (meth) acrylate having a phosphate group or a thiophosphate group, particularly in view of adhesiveness to enamel.
Here, the (meth) acrylate having an acid group may have a plurality of acid groups.
Instead of the (meth) acrylate having an acid group, an acid chloride, an alkali metal salt, and an amine salt of the (meth) acrylate having an acid group may be used.
Examples of the (meth) acrylate having a phosphoric acid group include 2- (meth) acryloyloxyethyl dihydrogen phosphate, bis [2- (meth) acryloyloxyethyl ] hydrogen phosphate, 2- (meth) acryloyloxyethyl phenyl hydrogen phosphate, 6- (meth) acryloyloxyethyl phenyl hydrogen phosphate, 10- (meth) acryloyloxyethyl dihydrogen phosphate (10- (meth) acryloyloxyethyl dihydrogen phosphate), 1- (meth) acryloyloxypropyl 1-bis (2- (meth) acryloyloxyethyl) hydrogen phosphate, 3-di (meth) acryloxypropan-2-dihydrogenphosphate, 1,3-di (meth) acryloxypropanol-2-phenylphosphonate (1,3-di (meth) acryloxypropan-2-phenylphosphonate), bis [5- {2- (meth) acryloxyethoxycarbonyl } heptyl ] hydrogenphosphate (bis [5- {2- (meth) acryloxyethoxycarbonyl } hexyl ] hydroxyphenyl ] phosphate), and the like. Among them, 10-methacryloyloxydecyl dihydrogen phosphate is preferably used from the viewpoint of the adhesiveness of the dental polymerizable composition of the present embodiment.
Examples of the (meth) acrylate having a pyrophosphate group include bis [2- (meth) acryloyloxyethyl ] pyrophosphate (bis (2- (meth) acryloyloxybutyl) pyrophosphate), bis [4- (meth) acryloyloxybutyl ] pyrophosphate (bis (4- (meth) acryloyloxybutyl) pyrophosphate), bis [6- (meth) acryloyloxyhexyl ] pyrophosphate (bis (6- (meth) acryloyloxyhexyl) pyrophosphate), bis [8- (meth) acryloyloxyoctyl ] pyrophosphate (bis (8- (meth) acryloyloxyoctyl) pyrophosphate), bis [10- (meth) acryloyloxydecyl ] pyrophosphate (bis (10- (meth) acryloyloxysylcystyl) and the like.
Examples of the (meth) acrylate having a thiophosphoric acid group include 2- (meth) acryloyloxyethyl dihydrogen thiophosphate (2- (meth) acryloyloxyhexyl dihydrogen thiophosphate), 3- (meth) acryloyloxypropyl dihydrogen thiophosphate, 4- (meth) acryloyloxybutyl dihydrogen thiophosphate, 5- (meth) acryloyloxypentyl dihydrogen thiophosphate, 6- (meth) acryloyloxyhexyl dihydrogen thiophosphate, 7- (meth) acryloyloxyheptyl dihydrogen thiophosphate, 8- (meth) acryloyloxyoctyl dihydrogen thiophosphate, 9- (meth) acryloyloxynonyl dihydrogen thiophosphate, 10- (meth) acryloyloxydecyl dihydrogen thiophosphate, 11- (meth) acryloyloxyundecyl dihydrogen thiophosphate, 2- (meth) acryloyloxyethyl dihydrogen thiophosphate, 3- (meth) acryloyloxy-propyl dihydrogen thiophosphate, 4- (meth) acryloyloxybutyl thiophosphate, 5- (meth) acryloyloxy-pentyl-thio-phosphate, 6- (meth) acryloyloxyhexyl-hexyl-thio-phosphate, 7- (meth) acryloyloxyundecyl-thio phosphate, 2- (meth) acryloyloxy-undecyl-thio phosphate, 2- (meth) phosphorothioate, and 1- (meth) acryloyloxy-decyl-thio phosphate, 12- (meth) acryloyloxydodecyl thiophosphate, 13- (meth) acryloyloxytridecyl thiophosphate, 14- (meth) acryloyloxytetradecyl thiophosphate, 15- (meth) acryloyloxytentadecyl thiophosphate, 16- (meth) acryloyloxytexadecyl thiophosphate, 17- (meth) acryloyloxyteptadecyl thiophosphate, 18- (meth) acryloyloxytadecyl thiophosphate, 19- (meth) acryloyloxytetradecyl thiophosphate, 20- (meth) acryloyloxyticosyl thiophosphate, etc.
Examples of the (meth) acrylate having a carboxyl group include 4- (meth) acryloyloxyethyl trimellitic acid (4- (meth) acryloyloxyethyl trimetallic acid), 4- (meth) acryloyloxyethyl trimellitic anhydride (4- (meth) acryloyloxyethyl trimetallic anhydride), 4- (meth) acryloyloxydecyl trimellitic anhydride (4- (meth) acryloyloxydecyl trimellitic anhydride), 11- (meth) acryloyloxy-1, 1-undecyldicarboxyl (11- (meth) acryloyloxy-1, 1-undecarboxylic acid), 1,4-di (meth) acryloyloxydecyl pyromellitic acid (1, 4-acryloyloxy) pyromellitic acid (2- (meth) acryloyloxyethyl methacrylate), and 4- (meth) acryloyloxyethyl trimellitic anhydride (4- (meth) acryloyloxydecyl trimetallic acid (4-acryloyloxy) and 4-di (meth) acryloxyethyl methacrylate (2- (meth) acrylic acid, 2- (meth) acryloyloxyethylphthalic acid (2- (meth) acryloyloxyethylphthalic acid), 2- (meth) acryloyloxyethylhexahydrophthalic acid (2- (meth) acryloyloxyethylphthalic acid), and the like.
Examples of the (meth) acrylate having a sulfonic acid group include 2- (meth) acrylamido-2-methylpropanesulfonic acid (2- (meth) acrylamide-2-methylpropanesulfonic acid), styrenesulfonic acid (styrenesulfonic acid), and 2-ethanesulfonate (2-sulfoethyl (meth) acrylate).
Examples of the (meth) acrylate having a phosphonic acid group include 2- (meth) acryloyloxyethylphenylphosphonate (2- (meth) acryloyloxyethylphenylphosphonate), 5- (meth) acryloyloxypentyl-3-phosphonopropionate (5- (meth) acryloyloxypentyl-3-phosphonopropionate), 6- (meth) acryloyloxyhexyl-3-phosphonopropionate (6- (meth) acryloyloxyhexyl-3-phosphonopropionate), 10- (meth) acryloyloxydecyl-3-phosphonopropionate (10- (meth) acryloyloxydecyl-3-phosphonopropionate), 6- (meth) acryloyloxyhexyl-3-phosphonoacetate (6- (meth) acryloyloxyhexyl-3-phosphonoacetate), 10- (meth) acryloyloxydecyl-3-phosphonoacetate (10- (meth) acryloyloxydecyl-3-phosphonoacetate) and the like.
The content of the (meth) acrylate having an acid group in the polymerizable composition for dental use of the present embodiment is preferably 0.1 to 20% by mass, and more preferably 0.5 to 10% by mass. When the content of the (meth) acrylate having an acid group in the polymerizable composition for dental use of the present embodiment is 0.1% by mass or more, the adhesiveness of the polymerizable composition for dental use of the present embodiment to dentin can be further improved, and when the content is 20% by mass or less, the hardening property of the polymerizable composition for dental use of the present embodiment can be further improved.
< 5-valent vanadium Compound >
The vanadium compound having a valence of 5 functions as a polymerization accelerator.
The vanadium 5-valent compound is preferably soluble in the (meth) acrylate.
The vanadium 5 valent compound is preferably an organovanadium compound. This can improve the solubility of the 5-valent vanadium compound in the dental polymerizable composition of the present embodiment in the (meth) acrylate.
The vanadium 5-valent compound is preferably vanadium oxytrialkoxide (vanadia oxytrialkoxide). This can improve the storage stability of the dental polymerizable composition of the present embodiment.
Examples of the vanadium trihydrocarbyloxyoxide include vanadium triisopropoxide (vanadia oxytrisopropoxide), vanadium tripropoxide (vanadia oxytropoxide), and vanadium triethoxyoxide (vanadia oxytetrahydroxide).
Examples of the 5-valent vanadium compound other than vanadium trihydrocarbyloxyoxide include vanadium oxychloride (vanadiumoxytrichloride).
Further, the 5-valent vanadium compound may be used alone, or two or more kinds may be used in combination.
The content of the 5-valent vanadium compound in the dental polymerizable composition of the present embodiment is preferably 0.001 to 1% by mass, and more preferably 0.01 to 0.1% by mass. When the content of the vanadium compound having a valence of 5 in the polymerizable composition for dental use of the present embodiment is 0.001% by mass or more, the curability of the polymerizable composition for dental use of the present embodiment can be improved, and when the content is 1% by mass or less, the storage stability of the polymerizable composition for dental use of the present embodiment can be improved.
For the same reason as described above, the content of the 5-valent vanadium compound in the first material is preferably 0.002 to 2 mass%, more preferably 0.02 to 0.2 mass%.
< Thiourea derivatives >
The thiourea derivative functions as a reducing agent for the chemical polymerization initiator.
Examples of the thiourea derivatives include ethylene thiourea (ethylene thiourea), N-methyl thiourea (N-methylthiothiourea), N-ethyl thiourea (N-ethylthiourea), N-propylthiourea (N-propylthiourea), N-butylthiourea (N-butylthiourea), N-lauryl thiourea (N-laurylthiourea), N-phenylthiourea (N-phenylthiourea), N-cyclohexylthiourea (N-cyclohexylthiourea), N-dimethylthiourea (N, N-dimethylthiourea), N-diethylthiourea (N, N-diethylthiourea), N-dipropylthiourea (N, N-dipropylthiourea), N-dibutylthiourea (N, N-dibutylthiourea), N-dipropylthiourea (N, N-dipropylthiourea), N-diphenylthiourea (N, N-laurylthiourea), n-diphenylthiourea), N-dicyclohexylthiourea (N, N-dicyclohexylthiourea), trimethylthiourea (trimethylthiourea), tetramethylthiourea (tetramethylthiourea), N-acetylthiourea (N-acetylthiourea), n-benzoylthiourea (N-benzoyl thiourea), 1-allyl-3- (2-hydroxyethyl) -2-thiourea (1-allyl-3- (2-hydroxyethoxy) -2-thiourea), 1- (2-tetrahydrofurfuryl) -2-thiourea (1- (2-tetrahydrofurfuryl) -2-thiourea), N-tert-butyl-N '-isopropylthiourea (N-tert-butyl-N' -isopropylthiourea), 2-pyridylthiourea (2-pyridylthiourea), and the like, and two or more kinds may be used in combination. Among these, N-benzoylthiourea is preferably used from the viewpoint of curability of the dental polymerizable composition of the present embodiment.
The content of the thiourea derivative in the polymerizable composition for dental use of the present embodiment is preferably 0.1 to 5% by mass, and more preferably 0.1 to 1% by mass. When the content of the thiourea derivative in the polymerizable composition for dental use of the present embodiment is 0.1% by mass or more, the curability of the polymerizable composition for dental use of the present embodiment can be improved, and when the content is 5% by mass or less, the solubility of the (meth) acrylate of the thiourea derivative in the polymerizable composition for dental use of the present embodiment can be improved.
For the same reason as described above, the content of the thiourea derivative in the first agent is preferably 0.2 to 10% by mass, and more preferably 0.2 to 2% by mass.
< organic peroxide >
The organic peroxide functions as an oxidizing agent of the chemical polymerization initiator.
Examples of the organic peroxide include benzoyl peroxide (cumene hydroperoxide), cumene hydroperoxide (cumene hydroperoxide), t-butyl hydroperoxide (t-butyl hydroperoxide), t-amyl alcohol peroxide (t-amyl hydroperoxide), 1,3,3-tetramethylbutyl hydroperoxide (1,1,3,3-tetramethylbutyl hydroperoxide), 2,5-dimethyl-2,5-di (hydroperoxide) hexane (2,5-dimethyl-2,5-di (hydroperoxide) hexane), p-diisopropylbenzene hydroperoxide (p-isopropylbenzene hydroperoxide), p-methane hydroperoxide (p-methyl hydroperoxide), pinane hydroperoxide (pinane hydroperoxide), and the like, and two or more kinds of these may be used in combination. Among these, cumene hydroperoxide is preferably used for the hardening properties of the dental polymerizable composition of the present embodiment.
The content of the organic peroxide in the polymerizable composition for dental use of the present embodiment is preferably 0.01 to 5% by mass, and more preferably 0.1 to 2% by mass. When the content of the organic peroxide in the polymerizable composition for dental use of the present embodiment is 0.01% by mass or more, the curability of the polymerizable composition for dental use of the present embodiment can be improved, and when the content is 5% by mass or less, the working margin of the polymerizable composition for dental use of the present embodiment can be extended.
For the same reason as described above, the content of the organic peroxide in the second material is preferably 0.02 to 10% by mass, and more preferably 0.2 to 4% by mass.
< other ingredients >
The first charge agent may also contain a tertiary amine.
The tertiary amine functions as a reducing agent for the chemical polymerization initiator.
The tertiary amine may be any of aliphatic tertiary amines and aromatic tertiary amines, preferably aromatic tertiary amines, and particularly preferably alkyl p-dialkylaminobenzoates.
Examples of the aliphatic tertiary amine include N, N-dimethylaminoethyl methacrylate (N, N-dimethylethylenediamine), triethanolamine (triethanolamine), and the like.
Examples of the alkyl p-dialkylaminobenzoate include methyl p-dimethylaminobenzoate, ethyl p-dimethylaminobenzoate, propyl p-dimethylaminobenzoate, amyl p-dimethylaminobenzoate, isoamyl p-dimethylaminobenzoate, ethyl p-dimethylaminobenzoate, and propyl p-dimethylaminobenzoate.
Examples of tertiary aromatic amines other than alkyl p-dialkylaminobenzoates include 7-dimethylamino-4-methylcoumarin (7-dimethylamino-4-methylcoumarin), N-dimethylaniline (N, N-dimethylaniline), N-dibenzylaniline (N, N-dibenzylaniline), N-dimethyl-p-toluidine (N, N-dimethyl-p-toluidine), N-diethyl-p-toluidine (N, N-diethyl-p-toluidine), N-bis (2-hydroxyethyl) p-toluidine (N, N-bis (2-hydroxyethoxy) -p-toluidine), N,2,4,6-pentamethylaniline (N, 2,4, 6-pentatoluidine), N,2,4-tetramethylaniline (N, n,2, 4-tetramethyllaniline), N-diethyl-2,4,6-trimethylaniline (N, N-diethyl-2,4, 6-trimethyllaniline), and the like.
Here, the tertiary amine may be used alone, or two or more of them may be used in combination.
The first and/or second additives may further include a polymerization inhibitor, a photopolymerization initiator, a filler, and the like.
Examples of the polymerization inhibitor include dibutylhydroxytoluene (dibutyl hydroxytoluene), 6-tert-butyl-2,4-xylenol (6-tert-butyl-2,4-xylenol), 2,6-di-tert-butyl-p-cresol (2,6-di-tert-butyl-p-cresol), and two or more kinds thereof may be used in combination.
Examples of the photopolymerization initiator include camphorquinone (camphorquinone), phenylbis (2,4,6-trimethylbenzoyl) phosphine oxide (phenylbis (2,4,6-trimethylbenzoyl) phosphinide), 2,4, 6-trimethylbenzoyldiphenylphosphine (2,4, 6-trimethylbenzoyldiphenylphosphine), benzyl ketal (benzyl ketal), diacetyl ketal (diacetyl ketal), benzyl dimethyl ketal (benzyl dimethyl ketal), benzyl diethyl ketal (benzyl diethyl ketal), benzyl bis (2-methoxyethyl) ketal (2-methylhexyl) ketal), 4'-dimethyl (benzyl dimethyl ketal) (4,4' -dimethyl (benzyl dimethyl ketal), anthraquinone (chromaquinone), 1-chloroanthraquinone (1-chloroanthraquinone), 1-chloroanthraquinone (1-2-chloroanthraquinone (1, 2-chloroanthraquinone), 2-benzanthraquinone), 1-hydroxyanthraquinone (1-hydroxyanthraquinone), 1-methylanthraquinone (1-methyllanthraquinone), 2-ethylanthraquinone (2-ethyllanthraquinone), 1-bromoanthraquinone (1-bromoanthraquinone), thioxanthone (thioxanthone), 2-isopropylthioxanthone (2-isopropylthioxanthone), 2-nitrothioxanthone (2-nitrothioxanthone), 2-methylthiothioxanthone (2-methylthioxanthone), 2,4-dimethylthioxanthone (2,4-dimethylthioxanthone), 2,4-diethylthioxanthone (2,4-dimethylthioxanthone), 2,4-diisopropylthioxanthone (2, 4-dioxothioxanthone), 2-chlorothioxanthone (7-chlorothioxanthone), 2,4-diisopropylthioxanthone (2,4-dimethylthioxanthone), 2-chlorothioxanthone (7-chlorothioxanthone-10-fluoroxanthone (10-trifluoromethylthioxanthone), and mixtures thereof, Thioxanthone-10-oxide (thioxanthone-10-oxide), benzoin methyl ether (benzoin methyl ether), benzoin ethyl ether (benzoin ethyl ether), benzoin isopropyl ether (benzoin isopropyl ether), benzoin isobutyl ether (benzoin isopropyl ether), benzophenone (benzophenone), bis (4-dimethylaminophenyl) ketone, 4'-bis (diethylamino) phenyl ketone (4,4' -bis (diethylamino) benzophenone), and the like, and two of them may be used in combination.
Examples of the filler include anhydrous silicic acid powder, fumed silica (fumed silica), aluminum powder, and glass powder (for example, barium glass powder and fluoroaluminosilicate (fluoroaluminosilicate) glass powder). Two or more kinds may be used in combination.
Here, the filler may be treated with a surface treatment agent such as a silane coupling agent.
The content of the filler in the dental polymerizable composition of the present embodiment is preferably 4 to 90% by mass, and more preferably 15 to 80% by mass. When the content of the filler in the dental polymerizable composition of the present embodiment is 4% by mass or more, the mechanical strength of the hardened body of the dental polymerizable composition of the present embodiment can be improved, and when the content is 90% by mass or less, the workability of the dental polymerizable composition of the present embodiment can be improved.
[ examples ]
Examples of the present disclosure are described below, but the disclosure is not limited to the examples.
Examples 1 to 9 and comparative examples 1 to 3
(preparation of paste 1)
An acid-free methacrylate, a 5-valent vanadium compound, a thiourea derivative, a filler, a tertiary amine, a photopolymerization initiator, and a polymerization inhibitor were mixed in a ratio [ mass% ] shown in table 1 to obtain paste 1.
(preparation of paste 2)
A paste 2 was obtained by mixing an acid group-free methacrylate, an acid group-containing methacrylate, an organic peroxide, a filler and a polymerization inhibitor in the proportions [ mass% ] shown in table 1.
Here, the abbreviations shown in table 1 have the following meanings.
Bis-GMA 2,2-Bis [4- (3-methacryloyloxy-2-hydroxypropyl) phenyl ] propane (2,2-Bis [4- (3-methacryloyloxy-2-hydroxypropyl) phenyl ] propane)
UDMA Di-2-methacryloyloxyethyl-2,2,4-trimethylhexamethylene dicarbamate (di-2-methacryloyloxyethyl-2,2,4-trimethylhexamethylene dicarbamate)
EBDMA Ethoxylated bisphenol A dimethacrylate (Ethoxylated bisphenol-acrylate)
NPG neopentyl glycol dimethacrylate (Neoprene)
TEGDMA Triethylene glycol dimethacrylate (Triethylglycol dimethacrylate)
MDP 10-methacryloxydecyl dihydrogen phosphate (10-methacryloxydecyldihydrogenphosphate)
HOMS 2-methacryloyloxyethylsuccinic acid (2-methacryloyloxyethylsuccinic acid)
TIPOVO Triisopropoxyvanadia (vanadia oxytriisoproxide)
TPOVO vanadium oxytripropoxide (vanadia oxytriproxide)
TEOVO vanadium trioxide (vanadia)
VAA vanadium (IV) oxide (vanadyl acetylacetonate (bis (2, 4-pentanedioate))
NBTU benzoyl thiourea (N-benzoyl thiourea)
CHP cumene hydroperoxide (cumene hydroperoxide)
Filler 1 barium glass powder G018-053 UFO0.4 (manufactured by SCHOTT)
Filler 2 (hydrophobic fumed silica) AEROSILRX300 (manufactured by AEROSIL, Japan)
Filler 3 Anhydrous silicic acid powder RAF1000 (manufactured by Longsen)
EPA Ethyl p-dimethylaminobenzoate
CQ is camphorquinone
BHT dibutylhydroxytoluene
Then, the storage stability of the pastes 1 and 2 (polymerizable dental compositions) was evaluated.
(storage stability)
In order to evaluate the storage stability of the dental polymerizable composition, an accelerated test was performed. Specifically, pastes 1 and 2 were stored at 60 ℃ for 14 days. Next, the pastes 1 and 2 before and after storage were mixed at a mass ratio of 1:1, and then the hardening time was measured to evaluate the storage stability of the polymerizable composition for dental use. Specifically, the mixture of pastes 1 and 2 was packed in an acrylic ring having an inner diameter of 8mm and a thickness of 2mm, and then the temperature was measured using an infrared thermometer to obtain the curing time.
Further, the evaluation criteria of storage stability are as follows.
Preferably, the change in the curing time of the dental polymerizable composition before and after storage is 3 minutes or less
Good that the change in the curing time of the dental polymerizable composition before and after storage exceeds 3 minutes, but is 4 minutes or less
Failure that the change in the curing time of the dental polymerizable composition before and after storage exceeded 4 minutes
The results of evaluating the storage stability of the dental polymerizable composition are shown in tables 1 and 2.
TABLE 1
Figure BDA0002984334840000131
TABLE 2
Figure BDA0002984334840000141
From tables 1 and 2, it is clear that the polymerizable compositions for dental use of examples 1 to 9 have high storage stability.
In contrast, the polymerizable dental compositions of comparative examples 1 to 3 did not contain a vanadium compound having a valence of 5, but used vanadyl acetylacetonate paste 1 containing a vanadium compound having a valence of 4, and thus had low storage stability.

Claims (3)

1. A dental polymerizable composition, wherein,
the method comprises the following steps:
a first agent comprising a (meth) acrylate, a 5-valent vanadium compound, and a thiourea derivative; and
and a second agent comprising a (meth) acrylate and an organic peroxide.
2. The dental polymerizable composition according to claim 1,
the 5-valent vanadium compound is an organic vanadium compound.
3. The dental polymerizable composition according to claim 2,
the vanadium 5-valent compound is vanadium trihydrocarbyloxy oxide.
CN202110295880.XA 2020-03-24 2021-03-19 Dental polymerizable composition Active CN113440418B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2020-053184 2020-03-24
JP2020053184A JP2021151969A (en) 2020-03-24 2020-03-24 Dental polymerizable composition

Publications (2)

Publication Number Publication Date
CN113440418A true CN113440418A (en) 2021-09-28
CN113440418B CN113440418B (en) 2023-12-26

Family

ID=74947193

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202110295880.XA Active CN113440418B (en) 2020-03-24 2021-03-19 Dental polymerizable composition

Country Status (6)

Country Link
US (1) US11571368B2 (en)
EP (1) EP3884921A1 (en)
JP (1) JP2021151969A (en)
CN (1) CN113440418B (en)
AU (1) AU2021201550B2 (en)
BR (1) BR102021004159A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4205723A1 (en) * 2021-12-29 2023-07-05 Ivoclar Vivadent AG High transparency, sulphate-containing or phosphate-containing dental self-adhering composite

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2163234A1 (en) * 2007-06-07 2010-03-17 Tokuyama Dental Corporation Dental filling/restoration kit
EP2425808A1 (en) * 2010-09-03 2012-03-07 GC Corporation Polymerizable composition
EP3342393A1 (en) * 2015-08-28 2018-07-04 GC Corporation Dental cement
CN108366910A (en) * 2015-12-18 2018-08-03 可乐丽则武齿科株式会社 Dental adhesive material is set with

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5363843B2 (en) 2008-03-19 2013-12-11 株式会社トクヤマデンタル Dental filling and repair kit
CN105101935B (en) * 2013-03-28 2018-02-23 可乐丽则武齿科株式会社 Solidification compound
JP2020053184A (en) 2018-09-25 2020-04-02 東芝ライテック株式会社 Illuminating device

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2163234A1 (en) * 2007-06-07 2010-03-17 Tokuyama Dental Corporation Dental filling/restoration kit
EP2425808A1 (en) * 2010-09-03 2012-03-07 GC Corporation Polymerizable composition
EP3342393A1 (en) * 2015-08-28 2018-07-04 GC Corporation Dental cement
CN108366910A (en) * 2015-12-18 2018-08-03 可乐丽则武齿科株式会社 Dental adhesive material is set with

Also Published As

Publication number Publication date
BR102021004159A2 (en) 2021-10-05
AU2021201550A1 (en) 2021-10-14
AU2021201550B2 (en) 2022-02-17
EP3884921A1 (en) 2021-09-29
CN113440418B (en) 2023-12-26
US20210299000A1 (en) 2021-09-30
JP2021151969A (en) 2021-09-30
US11571368B2 (en) 2023-02-07

Similar Documents

Publication Publication Date Title
US11998622B2 (en) Dental cement compositions and methods of use
JP7233554B2 (en) Dental polymerizable composition
JP7297076B2 (en) Polymerization initiator composition
CN113440418A (en) Dental polymerizable composition
JP6734254B2 (en) Dental composition and dental prosthesis bonding kit
WO2023054284A1 (en) Dental adhesive composition
JP2019178119A (en) Dental polymerizable composition
EP4029490A1 (en) Polymerizable dental composition
JP6887398B2 (en) Dental Composition and Dental Prosthesis Adhesive Kit
JP6713819B2 (en) Dental adhesive set
JP7504638B2 (en) Dental polymerizable composition
WO2023188631A1 (en) Glass composition
WO2021059645A1 (en) Dental composition and dental restoration kit
US20240189195A1 (en) Dental polymerizable composition
WO2023053787A1 (en) Method for producing dental filler, dental filler, and dental composition
WO2023190678A1 (en) Adhesive composition for dental use

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant